AM0010: Additional Phase I data

Data from a cohort of 19 evaluable patients with advanced melanoma, renal cell carcinoma (RCC) or non-small cell lung cancer (NSCLC) in an open-label, U.S. Phase Ib trial showed that once-daily subcut...